SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-20-215352
Filing Date
2020-08-11
Accepted
2020-08-10 21:52:28
Documents
6

Document Format Files

Seq Description Document Type Size
1 SC TO-C d948683dsctoc.htm SC TO-C 22722
2 EX-99.1 d948683dex991.htm EX-99.1 32777
3 EX-99.2 d948683dex992.htm EX-99.2 1133
4 GRAPHIC g948683g0811065812548.jpg GRAPHIC 10010
5 GRAPHIC g948683g10w61.jpg GRAPHIC 2642
6 GRAPHIC g948683g83o64.jpg GRAPHIC 2757
  Complete submission text file 0001193125-20-215352.txt   79863
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filed by) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10790 ROSELLE STREET SAN DIEGO CA 92121
Business Address 10790 ROSELLE STREET SAN DIEGO CA 92121 858-352-4400
Pfenex Inc. (Subject) CIK: 0001478121 (see all company filings)

IRS No.: 271356759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-88253 | Film No.: 201090937
SIC: 2834 Pharmaceutical Preparations